Tous les communiqués de presse

- FDA approval for NDI status

Voir le communiqué de presse

- Strategic transformation plan (IN FRENCH).

Voir le communiqué de presse

- Eurofragance and Alphanosos join forces to address malodors.

Voir le communiqué de presse

- Appointment of Maria Wiltz as Director in charge of Group Business Development Strategy at METabolic EXplorer as part of its strategic transformation plan (IN FRENCH).

Voir le communiqué de presse

- Rudolph Hidalgo appointed Deputy CEO of METabolic EXplorer Group as part of its strategic transformation plan (IN FRENCH).

Voir le communiqué de presse

- Consolidated sales for the third quarter of 2022: €54.8 million (IN FRENCH).

Voir le communiqué de presse

- Valbiotis: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes.

Voir le communiqué de presse

- 2023 Semi-Annual Results (IN FRENCH).

Voir le communiqué de presse

- Valbiotis publishes its financial report for the first half of 2023 and confirms its strategic roadmap.

Voir le communiqué de presse

- “Accelerate your plant innovation!” VEGEPOLYS VALLEY launches the 8th edition of its contest dedicated to startups

Voir le communiqué de presse